With effect from 1 April
Peder Holk Nielsen
Danish enzymes manufacturer Novozymes has appointed Peder Holk Nielsen as president and chief executive officer. He takes up the role on 1 April, succeeding Steen Riisgaard, who steps down after 12 years in the role.
Holk Nielsen is currently Novozymes’ executive vice president and head of the Enzyme Business, a position he has held since 2007. Prior to this, his career spans management positions in Novozymes and Novo Industri/Novo Nordisk across business development, R&D, quality management and sales and marketing.
Steen Riisgaard steps down after 12 years at the company’s top post and 33 years at Novozymes and Novo Industri/Novo Nordisk.
Since 2000, Novozymes has delivered average annual growth rates of 7–8% and increased returns of invested capital from 10–20%. The company now holds 47% of the global market for industrial enzymes and spearheads the increasing use of micro-organisms and industrial biotechnology products across a range of industries.
The new executive leadership team at 1 April, will comprise:
